
Sign up to save your podcasts
Or


Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
By The Lancet NeurologyJeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.

43,580 Listeners

293 Listeners

517 Listeners

50 Listeners

112,238 Listeners

93 Listeners

513 Listeners

190 Listeners

61 Listeners

83 Listeners

0 Listeners